Search

Search Constraints

You searched for: Author/Creator Kshemendran, Sajeev

Search Results

1. Assessing the relationship between cognitive dysfunction and brain atrophy in Alzheimer's disease: Neuroimaging / multi‐modal comparisons. (7th December 2020)

2. Behavioural symptoms in Alzheimer's disease are associated with white matter lesions (WML) volume and are independent of atrophy and hypometabolism: Neuroimaging / Optimal neuroimaging measures for tracking disease progression. (7th December 2020)

3. Evaluation of liraglutide in the treatment of Alzheimer's disease. (31st December 2021)

4. Evaluation of liraglutide in the treatment of Alzheimer's disease. (31st December 2021)

5. Influence of cerebral glucose metabolic rate on cognitive function in Alzheimer's subjects: Neuroimaging / multi‐modal comparisons. (7th December 2020)

6. P2‐358: INSULIN RESISTANCE INFLUENCES HIPPOCAMPAL GLUCOSE METABOLISM RATHER THAN HIPPOCAMPAL VOLUME IN NON‐DIABETIC ALZHEIMER'S DISEASE PATIENTS. (1st July 2019)

7. P3‐225: PERIPHERAL INSULIN RESISTANCE DOES NOT CORRELATE WITH CEREBRAL GLUCOSE METABOLIC RATE IN NON‐DIABETIC ALZHEIMER'S PATIENTS. (1st July 2006)

8. P3‐328: DOES INSULIN RESISTANCE INFLUENCE WHITE MATTER LESIONS IN NON‐DIABETIC AD SUBJECTS?. (1st July 2019)

9. Relationship between spectral analysis, SUV and SUV Pons ratio as a measure of cerebral glucose metabolic rate in Alzheimer's disease: Neuroimaging / multi‐modal comparisons. (7th December 2020)